Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jan;98(1):19-28.
doi: 10.1002/jnr.24331. Epub 2018 Sep 27.

Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets

Affiliations
Review

Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: Pathophysiology and potential therapeutic targets

Suraj Sulhan et al. J Neurosci Res. 2020 Jan.

Abstract

Traumatic Brain Injury (TBI) is the most frequent cause of death and disability in young adults and children in the developed world, occurring in over 1.7 million persons and resulting in 50,000 deaths in the United States alone. The Centers for Disease Control and Prevention estimate that between 3.2 and 5.3 million persons in the United States live with a TBI-related disability, including several neurocognitive disorders and functional limitations. Following the primary mechanical injury in TBI, literature suggests the presence of a delayed secondary injury involving a variety of neuroinflammatory changes. In the hours to days following a TBI, several signaling molecules and metabolic derangements result in disruption of the blood-brain barrier, leading to an extravasation of immune cells and cerebral edema. The primary, sudden injury in TBI occurs as a direct result of impact and therefore cannot be treated, but the timeline and pathophysiology of the delayed, secondary injury allows for a window of possible therapeutic options. The goal of this review is to discuss the pathophysiology of the primary and delayed injury in TBI as well as present several preclinical studies that identify molecular targets in the potential treatment of TBI. Additionally, certain recent clinical trials are briefly discussed to demonstrate the current state of TBI investigation.

Keywords: Blood-brain barrier; brain edema; neuroinflammation; traumatic brain injury.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: All authors declare that they have no conflict of interest.

References

    1. Abbott NJ, Patabendige AA, Dolman DE, Yusof SR, & Begley DJ (2010). Structure and function of the blood-brain barrier. Neurobiol Dis, 37(1), 13–25. doi:10.1016/j.nbd.2009.07.030 - DOI - PubMed
    1. Abdel Baki SG, Schwab B, Haber M, Fenton AA, & Bergold PJ (2010). Minocycline synergizes with N-acetylcysteine and improves cognition and memory following traumatic brain injury in rats. PLoS One, 5(8), e12490. doi:10.1371/journal.pone.0012490 - DOI - PMC - PubMed
    1. Abdul Muneer PM, Alikunju S, Szlachetka AM, & Haorah J (2012). The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion. Arterioscler Thromb Vasc Biol, 32(5), 1167–1177. doi:10.1161/ATVBAHA.112.247668 - DOI - PMC - PubMed
    1. Abdul-Muneer PM, Pfister BJ, Haorah J, & Chandra N (2016). Role of Matrix Metalloproteinases in the Pathogenesis of Traumatic Brain Injury. Mol Neurobiol, 53(9), 6106–6123. doi:10.1007/s12035-015-9520-8 - DOI - PMC - PubMed
    1. Abdul-Muneer PM, Schuetz H, Wang F, Skotak M, Jones J, Gorantla S, … Haorah J (2013). Induction of oxidative and nitrosative damage leads to cerebrovascular inflammation in an animal model of mild traumatic brain injury induced by primary blast. Free Radic Biol Med, 60, 282–291. doi:10.1016/j.freeradbiomed.2013.02.029 - DOI - PMC - PubMed

Publication types

MeSH terms